Speciality: Rheumatology
Description:
A warm welcome to all the medical professionals in this interesting session on the role of tofacitinib in managing rheumatoid arthritis.
Immunological pathways play a crucial role in disease management, especially in the case of rheumatological disease. Managing rheumatoid arthritis often becomes difficult due to its rate of progression and associated health issues.
The webinar will help in gaining important insights on JAK-inhibiting drugs like tofacitinib in controlling rheumatoid arthritis. It is a competitive inhibitor of JAK that binds to adenosine triphosphate in the kinase domain.
Tofacitinib inhibits the process of intracellular signaling from the receptor to the cellular nucleus and inhibits the inflammation process via inhibition of the Janus kinases, which eventually help in controlling rheumatoid arthritis.
Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Survival rates for incurable larynx cancer investigated for first time
2.
findings from the measurement of disability weights in China with an emphasis on the impact of disease burden.
3.
Knowing about and avoiding bladder cancer.
4.
The risk of ovarian cancer is not increased by salpingectomy, according to JAMA.
5.
Aspirin Fails to Boost Survival in Colorectal Cancer Trial
1.
Evidence-Based Approaches in Hematology for Modern Medicine
2.
Citizen-Centered Digital Health Navigation Systems: Advancing Patient Engagement and Optimizing Healthcare Delivery
3.
Surgery for Tracheoesophageal Fistula: What to Expect Before, During, and After
4.
The Statistical Horizon of Colorectal Cancer: From Global Trends to Precision Therapies and Colorectal Cancer 2025 Forecasts
5.
Is p53 the Missing Puzzle Piece? Exploring Its Polymorphisms in Cervical Cancer Risk
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
2.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
3.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
5.
Thromboprophylaxis In Medical Settings
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation